Moore Capital Management, LP Immunovant, Inc. Transaction History

Moore Capital Management, LP

  • $4.85 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$9.4 - $16.85 $226,662 - $406,304
-24,113 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$13.08 - $49.6 $1.9 Million - $7.21 Million
-145,430 Reduced 85.78%
24,113 $387,000
Q4 2020

Feb 16, 2021
BUY
$36.36 - $52.71 $4.17 Million - $6.05 Million
114,709 Added 209.19%
169,543 $7.83 Million
Q3 2020

Nov 16, 2020
BUY
$22.61 - $38.9 $1.24 Million - $2.13 Million
54,834 New
54,834 $1.93 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email